Yeragani V K, Pohl R, Aleem A, Balon R, Sherwood P, Lycaki H
Department of Psychiatry, Wayne State University School of Medicine, Detroit, MI.
Can J Psychiatry. 1988 Oct;33(7):606-10. doi: 10.1177/070674378803300706.
The symptom of carbohydrate craving and increased appetite (CHH) was studied in 180 outpatients receiving antidepressant treatment. One hundred and fifty-eight of these patients had a DSM-III diagnosis of panic disorder and 17, major depression. The incidence of CHH was similar in both diagnostic groups. Thus, antidepressant treatment is associated with CHH in patients with diagnoses, other than depression. Desipramine was least likely to induce CHH compared to imipramine, amitriptyline and doxepin. Most patients who developed CHH on imipramine no longer experienced this side effect when switched to desipramine. CHH was not more frequent among women and not associated with antidepressant dosage or treatment response. Histamine H-1 receptor blockade may be an important factor in the etiology of CHH.
对180名接受抗抑郁治疗的门诊患者的碳水化合物渴望和食欲增加(CHH)症状进行了研究。其中158名患者被诊断为惊恐障碍(DSM-III标准),17名被诊断为重度抑郁症。两个诊断组中CHH的发生率相似。因此,除抑郁症患者外,抗抑郁治疗与其他诊断患者的CHH有关。与丙咪嗪、阿米替林和多塞平相比,地昔帕明诱发CHH的可能性最小。大多数在服用丙咪嗪时出现CHH的患者换用地昔帕明后不再有这种副作用。CHH在女性中并不更常见,也与抗抑郁药剂量或治疗反应无关。组胺H-1受体阻断可能是CHH病因中的一个重要因素。